Business Context and Reporting Period
This Form 8-K is a current report filed by ReWalk Robotics Ltd. (noting the input metadata reference to "Lifeward Ltd." appears to be an error as the filing explicitly names ReWalk Robotics) on November 10, 2020. The filing serves to announce the company's financial results for the third quarter ended September 30, 2020. The company is incorporated in Israel and trades on the Nasdaq Capital Market under the symbol RWLK.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text. Consequently, no specific financial values can be extracted from this document.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that a press release detailing these results was issued on November 10, 2020.
Guidance, Outlook, and Management Commentary
Management hosted a conference call on November 10, 2020, at 8:30 a.m. E.D.T. to discuss the third-quarter financial results. An archived webcast of this call is available on the company's website under the "Investors" section. The filing explicitly states that the information contained in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for Q3 2020 by reviewing Exhibit 99.1 (the press release) referenced in this filing.
- Confirm the company's cash position and burn rate, as these are critical for a pre-revenue or early-stage medical device company but are not listed in this cover sheet.
- Review the archived conference call webcast for management's commentary on product development, regulatory approvals, and future guidance.
- Check for any updates on the company's liquidity status and whether additional capital raises are anticipated.